PAIN THERAPEUTICS INC's ticker is PTIE and the CUSIP is 69562K100. A total of 63 filers reported holding PAIN THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $183,000 | +57.8% | 205,197 | +0.5% | 0.00% | – |
| Q4 2016 | $116,000 | -42.9% | 204,153 | +0.3% | 0.00% | – |
| Q3 2016 | $203,000 | -54.4% | 203,457 | +0.1% | 0.00% | – |
| Q2 2016 | $445,000 | -1.8% | 203,283 | 0.0% | 0.00% | – |
| Q1 2016 | $453,000 | +27.2% | 203,283 | -0.1% | 0.00% | – |
| Q4 2015 | $356,000 | -4.0% | 203,457 | +0.2% | 0.00% | – |
| Q3 2015 | $371,000 | +6.0% | 203,109 | +0.2% | 0.00% | – |
| Q2 2015 | $350,000 | -17.1% | 202,761 | -9.3% | 0.00% | – |
| Q1 2015 | $422,000 | -4.7% | 223,619 | +2.2% | 0.00% | – |
| Q4 2014 | $443,000 | -48.1% | 218,700 | +0.2% | 0.00% | -100.0% |
| Q3 2014 | $853,000 | -26.0% | 218,265 | +8.9% | 0.00% | 0.0% |
| Q2 2014 | $1,152,000 | +20.9% | 200,460 | +15.6% | 0.00% | 0.0% |
| Q1 2014 | $953,000 | +16.8% | 173,400 | +3.2% | 0.00% | 0.0% |
| Q4 2013 | $816,000 | +78.9% | 168,087 | +0.2% | 0.00% | – |
| Q3 2013 | $456,000 | +50.5% | 167,797 | +22.3% | 0.00% | – |
| Q2 2013 | $303,000 | – | 137,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Street Partners, LLC | 1,707,764 | $9,819,643,000 | 9.95% |
| SOPHROSYNE CAPITAL LLC | 951,362 | $5,472,000 | 5.57% |
| GREAT POINT PARTNERS LLC | 1,694,256 | $9,742,000 | 4.33% |
| INTREPID CAPITAL MANAGEMENT INC /DE/ | 436,148 | $2,508,000 | 2.19% |
| AVALON CAPITAL MANAGEMENT | 110,837 | $637,000 | 0.53% |
| Visium Asset Management, LP | 4,350,000 | $25,013,000 | 0.39% |
| Cheyne Capital Management (UK) LLP | 25,000 | $144,000 | 0.17% |
| Gruss Capital Management LP | 600,000 | $3,450,000 | 0.17% |
| Capital Impact Advisors, LLC | 31,206 | $179,000 | 0.14% |
| TFS CAPITAL LLC | 292,036 | $1,679,000 | 0.13% |